1. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
   Sonam Roy et al, 2020, Pharmaceuticals CrossRef
2. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention
   Petra Grbčić et al, 2020, Current Medicinal Chemistry CrossRef
3. Integrative roles of sphingosine kinase in liver pathophysiology
   Kyu Min Kim et al, 2023, Toxicological Research CrossRef
4. Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
   Weiwei Shi et al, 2020, Frontiers in Oncology CrossRef
5. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance
   Priyanka Bhadwal et al, 2022, Scientific Reports CrossRef
6. Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors
   Shadia A. Galal et al, 2021, Medicinal Chemistry Research CrossRef
7. Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform
   Hongjie Chen et al, 2022, Journal of Oncology CrossRef
8. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
   Preeti Gupta et al, 2021, Cancers CrossRef
9. The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
   Run-Ze Li et al, 2022, Frontiers in Oncology CrossRef